TickerFactsScreenerDevelopers

KYNTRA BIO, INC. (KYNB) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $6.81M2014: $8.12M2015: $1.98M2016: $1.25M2017: $8.50M2018: $8.02M2019: $5.76M2020: $3.99M2021: $5.19M2022: $3.74M2023: $2.52M2024: $266.0K2025: $38.0K$38.0K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$38.0K-85.7%
2024$266.0K-89.4%
2023$2.52M-32.7%
2022$3.74M-27.9%
2021$5.19M+29.8%
2020$3.99M-30.7%
2019$5.76M-28.2%
2018$8.02M-5.6%
2017$8.50M+578.9%
2016$1.25M-36.7%
2015$1.98M-75.6%
2014$8.12M+19.3%
2013$6.81M—